Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
5.82
-0.11 (-1.85%)
May 20, 2026, 3:04 PM CST
Market Cap4.45B -4.9%
Revenue (ttm)2.99B +20.9%
Net Income38.74M -63.5%
EPS0.05 -63.9%
Shares Out749.98M
PE Ratio119.39
Forward PE19.77
Dividend0.10 (1.72%)
Ex-Dividend DateJun 6, 2025
Volume6,191,205
Average Volume8,787,898
Open5.88
Previous Close5.93
Day's Range5.81 - 5.92
52-Week Range5.56 - 8.06
Beta0.45
RSI44.44
Earnings DateApr 29, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Financial Statements